Re: FIVELAC is being WITHDRAWN!!! Be wary! The company is withdrawing the product DO NOT TAKE THE FIVELAC

It is simple. Go to google and search ENTEROCOCCUS FAECILIS. It is very astounding. When Threelac came out there were no clinicals on ENTEROCOCCUS FAECILIS. They originally thought it was nonpathogenic but they have discovered that was not correct. I challenge you to spend 10 minutes and research ENTEROCOCCUS FAECILIS and come back and dispute it. Here are a few things I found:




http://medinfo.ufl.edu/year2/mmid/bms5300/bugs/strfaeca.html


The enterococcus (previously Streptococcus faecalis), causes many of the same problems as other members of the intestinal flora. These include opportunistic urinary tract infections and wound infections


http://www.ebi.ac.uk/2can/genomes/genomes.html?http://www.ebi.ac.uk/2can/geno...


Scientists have identified a virulence region never seen before in the genome of Enterococcus faecalis - a leading cause of bacterial infection among hospital patients. There has long been concern about the dangers of Antibiotic resistance and its implications for the return of infectious diseases that cannot be effectively treated.


http://www.phac-aspc.gc.ca/msds-ftss/msds146e.html


Canada lists it as: MATERIAL SAFETY DATA SHEET - INFECTIOUS SUBSTANCES


http://en.wikipedia.org/wiki/Enterococcus_faecalis


Enterococcus faecalis is a Gram-positive commensal bacteria inhabiting the alimentary canals of humans and animals, are now acknowledged to be organisms capable of causing life-threatening infections in humans, especially in the nosocomial (hospital) environment. The existence of enterococci in such a dual role is facilitated, at least in part, by its intrinsic and acquired resistance to virtually all Antibiotics currently in use.
E. facaelis can cause endocarditis, as well as bladder, prostate, and epididymal infections; nervous system infections are less common.



http://www.jci.org/cgi/content/short/116/10/2799?rss=1


Increasing multidrug resistance in Enterococcus faecalis, a nosocomial opportunist and common cause of bacterial endocarditis, emphasizes the need for alternative therapeutic approaches such as immunotherapy or immunoprophylaxis.


http://content.nejm.org/cgi/content/short/332/1/26


Although Enterococcus faecalis was once regarded as nonpathogenic, this opportunistic gram-positive coccus now ranks among the most troublesome hospital pathogens. It has intrinsic resistance to many Antibiotics and a remarkable capacity for developing resistance to others.


http://www.pslgroup.com/dg/25d56.htm


Infections caused by Enterococcus faecalis include urinary tract, surgical wound, abdominal, pelvic and neonatal infections. Enterococcus faecalis is an important cause of endocarditis and mortality due to enterococcal bacteremia. It is estimated that well over 800,000 cases per year of enterococcus infections are reported in the U.S. alone, the third largest cause of hospital based infections. Many strains of Enterococcus faecalis are resistant to most Antibiotics and many have acquired resistance to vancomycin, rendering conventional therapies insufficient for serious infections.
Tweet